Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

A project to pick up undiagnosed COPD in people who had attended lung health checks found 70% had the condition.

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM) is set to grow from $11.5 billion in ...

By harnessing big data and machine learning (ML), a new generation of remote monitoring devices developed in Scotland is ...

Grace Anne Dorney Koppel was told she only had a few years left after her 2001 COPD diagnosis. Now, the couple provides the ...

Chiesi UK and Ireland, in partnership with Health Innovation Manchester, have launched the Improving Outcomes in Respiratory ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

Health experts have warned that turning on the central heating can make respiratory and sinus conditions worse as it causes ...

Software is being rolled out to 150 GP practices across Greater Manchester with the aim of supporting better adult asthma and COPD care.

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.